|
1
|
El-Salhy M, Gundersen D, Hatlebakk JG and
Hausken T: Irritable bowel syndrome. Nova Science Publisher. New
York: 2012.
|
|
2
|
Simrén M, Månsson A, Langkilde AM,
Svedlund J, Abrahamsson H, Bengtsson U and Björnsson ES:
Food-related gastrointestinal symptoms in the irritable bowel
syndrome. Digestion. 63:108–115. 2001. View Article : Google Scholar
|
|
3
|
Monsbakken KW, Vandvik PO and Farup PG:
Perceived food intolerance in subjects with irritable bowel
syndrome-etiology, prevalence and consequences. Eur J Clin Nutr.
60:667–672. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Williams EA, Nai X and Corfe BM: Dietary
intakes in people with irritable bowel syndrome. BMC Gastroenterol.
11:92011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
El-Salhy M, Ostgaard H, Gundersen D,
Hatlebakk JG and Hausken T: The role of diet in the pathogenesis
and management of irritable bowel syndrome (Review). Int J Mol Med.
29:723–731. 2012.PubMed/NCBI
|
|
6
|
Ostgaard H, Hausken T, Gundersen D and
El-Salhy M: Diet and effects of diet management on quality of life
and symptoms in patients with irritable bowel syndrome. Mol Med
Rep. 5:1382–1390. 2012.PubMed/NCBI
|
|
7
|
Biesiekierski JR, Rosella O, Rose R, Liels
K, Barrett JS, Shepherd SJ, Gibson PR and Muir JG: Quantification
of fructans, galacto-oligosacharides and other short-chain
carbohydrates in processed grains and cereals. J Hum Nutr Diet.
24:154–176. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Muir JG, Rose R, Rosella O, Liels K,
Barrett JS, Shepherd SJ and Gibson PR: Measurement of short-chain
carbohydrates in common Australian vegetables and fruits by
high-performance liquid chromatography (HPLC). J Agric Food Chem.
57:554–565. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Muir JG, Shepherd SJ, Rosella O, Rose R,
Barrett JS and Gibson PR: Fructan and free fructose content of
common Australian vegetables and fruit. J Agric Food Chem.
55:6619–6627. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
El-Salhy M: Ghrelin in gastrointestinal
diseases and disorders: A possible role in the pathophysiology and
clinical implications (review). Int J Mol Med. 24:727–732. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sandström O and El-Salhy M: Ageing and
endocrine cells of human duodenum. Mech Ageing Dev. 108:39–48.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sternini C, Anselmi L and Rozengurt E:
Enteroendocrine cells: A site of ‘taste’ in gastrointestinal
chemosensing. Curr Opin Endocrinol Diabetes Obes. 15:73–78. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moran GW, Leslie FC, Levison SE,
Worthington J and McLaughlin JT: Enteroendocrine cells: Neglected
players in gastrointestinal disorders? Therap Adv Gastroenterol.
1:51–60. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Coates MD, Mahoney CR, Linden DR, Sampson
JE, Chen J, Blaszyk H, Crowell MD, Sharkey KA, Gershon MD, Mawe GM
and Moses PL: Molecular defects in mucosal serotonin content and
decreased serotonin reuptake transporter in ulcerative colitis and
irritable bowel syndrome. Gastroenterology. 126:1657–1664. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dizdar V, Spiller R, Singh G, Hanevik K,
Gilja OH, El-Salhy M and Hausken T: Relative importance of
abnormalities of CCK and 5-HT (serotonin) in Giardia-induced
post-infectious irritable bowel syndrome and functional dyspepsia.
Aliment Pharmacol Ther. 31:883–891. 2010.PubMed/NCBI
|
|
16
|
El-Salhy M, Gilja OH, Gundersen D,
Hatlebakk JG and Hausken T: Duodenal chromogranin a cell density as
a biomarker for the diagnosis of irritable bowel syndrome.
Gastroenterol Res Pract. 2014:4628562014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
El-Salhy M, Gilja OH, Gundersen D,
Hatlebakk JG and Hausken T: Endocrine cells in the ileum of
patients with irritable bowel syndrome. World J Gastroenterol.
20:2383–2391. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
El-Salhy M, Gilja OH, Gundersen D and
Hausken T: Endocrine cells in the oxyntic mucosa of the stomach in
patients with irritable bowel syndrome. World J Gastrointest
Endosc. 6:176–185. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
El-Salhy M, Gilja OH and Hausken T:
Chromogranin A cells in the stomachs of patients with sporadic
irritable bowel syndrome. Mol Med Rep. 10:1753–1757.
2014.PubMed/NCBI
|
|
20
|
El-Salhy M, Gundersen D, Hatlebakk JG,
Gilja OH and Hausken T: Abnormal rectal endocrine cells in patients
with irritable bowel syndrome. Regul Pept. 188:60–65. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
El-Salhy M, Gundersen D, Ostgaard H,
Lomholt-Beck B, Hatlebakk JG and Hausken T: Low densities of
serotonin and peptide YY cells in the colon of patients with
irritable bowel syndrome. Dig Dis Sci. 57:873–878. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
El-Salhy M, Lillebø E, Reinemo A and
Salmelid L: Ghrelin in patients with irritable bowel syndrome. Int
J Mol Med. 23:703–707. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
El-Salhy M, Lomholt-Beck B and Hausken T:
Chromogranin A as a possible tool in the diagnosis of irritable
bowel syndrome. Scand J Gastroenterol. 45:1435–1439. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
El-Salhy M, Mazzawi T, Gundersen D and
Hausken T: Chromogranin A cell density in the rectum of patients
with irritable bowel syndrome. Mol Med Rep. 6:1223–1225.
2012.PubMed/NCBI
|
|
25
|
El-Salhy M, Vaali K, Dizdar V and Hausken
T: Abnormal small-intestinal endocrine cells in patients with
irritable bowel syndrome. Dig Dis Sci. 55:3508–3513. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
El-Salhy M, Wendelbo IH and Gundersen D:
Reduced chromogranin A cell density in the ileum of patients with
irritable bowel syndrome. Mol Med Rep. 7:1241–1244. 2013.PubMed/NCBI
|
|
27
|
Kim HS, Lim JH, Park H and Lee SI:
Increased immunoendocrine cells in intestinal mucosa of
postinfectious irritable bowel syndrome patients 3 years after
acute Shigella infection-an observation in a small case control
study. Yonsei Med J. 51:45–51. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Park JH, Rhee PL, Kim G, Lee JH, Kim YH,
Kim JJ, Rhee JC and Song SY: Enteroendocrine cell counts correlate
with visceral hypersensitivity in patients with
diarrhoea-predominant irritable bowel syndrome. Neurogastroenterol
Motil. 18:539–546. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang SH, Dong L, Luo JY, Gong J, Li L, Lu
XL and Han SP: Decreased expression of serotonin in the jejunum and
increased numbers of mast cells in the terminal ileum in patients
with irritable bowel syndrome. World J Gastroenterol. 13:6041–6047.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Spiller RC, Jenkins D, Thornley JP, Hebden
JM, Wright T, Skinner M and Neal KR: Increased rectal mucosal
enteroendocrine cells, T lymphocytes, and increased gut
permeability following acute Campylobacter enteritis and in
post-dysenteric irritable bowel syndrome. Gut. 47:804–811. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee KJ, Kim YB, Kim JH, Kwon HC, Kim DK
and Cho SW: The alteration of enterochromaffin cell, mast cell, and
lamina propria T lymphocyte numbers in irritable bowel syndrome and
its relationship with psychological factors. J Gastroenterol
Hepatol. 23:1689–1694. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mazzawi T, Hausken T, Gundersen D and
El-Salhy M: Effects of dietary guidance on the symptoms, quality of
life and habitual dietary intake of patients with irritable bowel
syndrome. Mol Med Rep. 8:845–852. 2013.PubMed/NCBI
|
|
33
|
Mazzawi T, Gundersen D, Hausken T and
El-Salhy M: Increased gastric chromogranin A cell density following
changes to diets of patients with irritable bowel syndrome. Mol Med
Rep. 10:2322–2326. 2014.PubMed/NCBI
|
|
34
|
Mazzawi T, Hausken T, Gundersen D and
El-Salhy M: Effect of dietary management on the gastric endocrine
cells in patients with irritable bowel syndrome. Eur J Clin Nutr.
69:519–524. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mazzawi T, Gundersen D, Hausken T and
El-Salhy M: Increased chromogranin a cell density in the large
intestine of patients with irritable bowel syndrome after receiving
dietary guidance. Gastroenterol Res Pract. 2015:8238972015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mazzawi T, Hausken T, Gundersen D and
El-Salhy M: Dietary guidance normalizes large intestinal endocrine
cells densities in patients with irritable bowel syndrome. Eur J
Clin Nutr. 70:175–181. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mazzawi T and El-Salhy M: Changes in small
intestinal chromogranin-A immunoreactive cells after patients with
irritable bowel syndrome receive dietary guidance Submitted.
2015.
|
|
38
|
Longstreth GF, Thompson WG, Chey WD,
Houghton LA, Mearin F and Spiller RC: Functional bowel disorders.
Gastroenterology. 130:1480–1491. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
World Medical Association: Declaration of
Helsinki. Ethical Principles for Medical Research Involving Human
Subjects. Jahrbuch für Wissenschaft Und Ethik. 14:233–238.
2009.
|
|
40
|
Meltzer HM, Brantsaeter AL, Ydersbond TA,
Alexander J and Haugen M: Methodological challenges when monitoring
the diet of pregnant women in a large study: experiences from the
Norwegian Mother and Child Cohort Study (MoBa). Matern Child Nutr.
4:14–27. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Rimestad AH, Borgejordet Å, Vesterhus KN,
Sygnestveit K, Løken EB and Trygg K: Den Store Matvaretabellen [The
Norwegian Food Composition Table]. Norwegian Food Safety Authority
(Oslo). 2001.(In Norwegian).
|
|
42
|
Masson LF, McNeill G, Tomany JO, Simpson
JA, Peace HS, Wei L, Grubb DA and Bolton-Smith C: Statistical
approaches for assessing the relative validity of a food-frequency
questionnaire: Use of correlation coefficients and the kappa
statistic. Public Health Nutr. 6:313–321. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Brantsaeter AL, Haugen M, Alexander J and
Meltzer HM: Validity of a new food frequency questionnaire for
pregnant women in the Norwegian Mother and Child Cohort Study
(MoBa). Matern Child Nutr. 4:28–43. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
El-Salhy M, Stenling R and Grimelius L:
Peptidergic innervation and endocrine cells in the human liver.
Scand J Gastroenterol. 28:809–815. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Enck P, Klosterhalfen S and Kruis W:
Determination of placebo effect in irritable bowel syndrome. Dtsch
Med Wochenschr. 130:1934–1937. 2005.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Abdul-Baki H, El Hajj II, Elzahabi L, Azar
C, Aoun E, Skoury A, Chaar H and Sharara AI: A randomized
controlled trial of imipramine in patients with irritable bowel
syndrome. World J Gastroenterol. 15:3636–3642. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zernicke KA, Campbell TS, Blustein PK,
Fung TS, Johnson JA, Bacon SL and Carlson LE: Mindfulness-based
stress reduction for the treatment of irritable bowel syndrome
symptoms: A randomized wait-list controlled trial. Int J Behav Med.
20:385–396. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Halmos EP, Power VA, Shepherd SJ, Gibson
PR and Muir JG: A diet low in FODMAPs reduces symptoms of irritable
bowel syndrome. Gastroenterology. 146:67–75.e5. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sandström O and el-Salhy M: Human rectal
endocrine cells and aging. Mech Ageing Dev. 108:219–226. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Lee J, Cummings BP, Martin E, Sharp JW,
Graham JL, Stanhope KL, Havel PJ and Raybould HE: Glucose sensing
by gut endocrine cells and activation of the vagal afferent pathway
is impaired in a rodent model of type 2 diabetes mellitus. Am J
Physiol Regul Integr Comp Physiol. 302:R657–R666. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Parker HE, Reimann F and Gribble FM:
Molecular mechanisms underlying nutrient-stimulated incretin
secretion. Expert Rev Mol Med. 12:e12010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Raybould HE: Nutrient sensing in the
gastrointestinal tract: Possible role for nutrient transporters. J
Physiol Biochem. 64:349–356. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
San Gabriel A, Nakamura E, Uneyama H and
Torii K: Taste, visceral information and exocrine reflexes with
glutamate through umami receptors. J Med Invest. 56(Suppl):
S209–S217. 2009.
|
|
54
|
Rudholm T, Wallin B, Theodorsson E,
Näslund E and Hellström PM: Release of regulatory gut peptides
somatostatin, neurotensin and vasoactive intestinal peptide by acid
and hyperosmolal solutions in the intestine in conscious rats.
Regul Pept. 152:8–122. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Sternini C: Taste receptors in the
gastrointestinal tract. IV. Functional implications of bitter taste
receptors in gastrointestinal chemosensing. Am J Physiol
Gastrointest Liver Physiol. 292:G457–G461. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Buchan AM: Nutrient tasting and signaling
mechanisms in the Gut III. Endocrine cell recognition of luminal
nutrients. Am J Physiol. 277:G1103–G1107. 1999.PubMed/NCBI
|
|
57
|
Montero-Hadjadje M, Elias S, Chevalier L,
Benard M, Tanguy Y, Turquier V, Galas L, Yon L, Malagon MM,
Driouich A, et al: Chromogranin A promotes peptide hormone sorting
to mobile granules in constitutively and regulated secreting cells:
Role of conserved N- and C-terminal peptides. J Biol Chem.
284:12420–12431. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Shooshtarizadeh P, Zhang D, Chich JF,
Gasnier C, Schneider F, Haïkel Y, Aunis D and Metz-Boutigue MH: The
antimicrobial peptides derived from chromogranin/secretogranin
family, new actors of innate immunity. Regul Pept. 165:102–110.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Gershon MD and Tack J: The serotonin
signaling system: From basic understanding to drug development for
functional GI disorders. Gastroenterology. 132:397–414. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Tack JF, Janssens J, Vantrappen G and Wood
JD: Actions of 5-hydroxytryptamine on myenteric neurons in guinea
pig gastric antrum. Am J Physiol. 263:G838–G846. 1992.PubMed/NCBI
|
|
61
|
Michel K, Sann H, Schaaf C and Schemann M:
Subpopulations of gastric myenteric neurons are differentially
activated via distinct serotonin receptors: Projection,
neurochemical coding, and functional implications. J Neurosci.
17:8009–8017. 1997.PubMed/NCBI
|
|
62
|
Tack J, Coulie B, Wilmer A, Andrioli A and
Janssens J: Influence of sumatriptan on gastric fundus tone and on
the perception of gastric distension in man. Gut. 46:468–473. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Gershon MD: Plasticity in serotonin
control mechanisms in the gut. Curr Opin Pharmacol. 3:600–607.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Gershon MD: 5-Hydroxytryptamine
(serotonin) in the gastrointestinal tract. Curr Opin Endocrinol
Diabetes Obes. 20:14–21. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Gershon MD: Serotonin is a sword and a
shield of the bowel: Serotonin plays offense and defense. Trans Am
Clin Climatol Assoc. 123:268–280; discussion 280. 2012.PubMed/NCBI
|
|
66
|
Gershon MD: Review article: Roles played
by 5-hydroxytryptamine in the physiology of the bowel. Aliment
Pharmacol Ther. 13(Suppl 2): S15–S30. 1999.
|
|
67
|
Gershon MD, Wade PR, Kirchgessner AL and
Tamir H: 5-HT receptor subtypes outside the central nervous system.
Roles in the physiology of the gut. Neuropsychopharmacology.
3:385–395. 1990.PubMed/NCBI
|
|
68
|
El-Salhy M, Mazzawi T, Gundersen D,
Hatlebakk JG and Hausken T: The role of peptide YY in
gastrointestinal diseases and disorders (review). Int J Mol Med.
31:275–282. 2013.PubMed/NCBI
|
|
69
|
El-Salhy M, Gilja OH, Gundersen D,
Hatlebakk JG and Hausken T: Interaction between ingested nutrients
and gut endocrine cells in patients with irritable bowel syndrome
(review). Int J Mol Med. 34:363–371. 2014.PubMed/NCBI
|
|
70
|
Höcker M and Wiedenmann B: Molecular
mechanisms of enteroendocrine differentiation. Ann N Y Acad Sci.
859:160–174. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Inokuchi H, Fujimoto S and Kawai K:
Cellular kinetics of gastrointestinal mucosa, with special
reference to gut endocrine cells. Arch Histol Jpn. 46:137–157.
1983. View Article : Google Scholar : PubMed/NCBI
|
